Watching Tonix Pharmaceuticals; Zacks Small-Cap Research Sets $14 Price Valuation
Portfolio Pulse from Benzinga Newsdesk
Zacks Small-Cap Research has set a $14 price valuation for Tonix Pharmaceuticals (TNXP), a significant increase from its current trading price.

June 21, 2023 | 2:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tonix Pharmaceuticals (TNXP) receives a $14 price valuation from Zacks Small-Cap Research, indicating a potential upside for the stock.
Zacks Small-Cap Research, a reputable research firm, has set a $14 price valuation for TNXP, which is significantly higher than its current trading price. This suggests that the stock has potential for growth in the short term, as investors may react positively to the new valuation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100